Literature DB >> 17190951

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

S J Cano1, J C Hobart, M Edwards, R Fitzpatrick, K Bhatia, A J Thompson, T T Warner.   

Abstract

We compared the responsiveness of the Cervical Dystonia Impact Profile (CDIP-58), Medical Outcome Study Short Form-Health Survey (SF-36), Functional Disability Questionnaire (FDQ), and Pain and Activities of Daily Living subscales of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in participants with cervical dystonia treated with botulinum toxin A. Subscales of CDIP-58 were more sensitive in detecting statistical and clinical change than comparable subscales of the SF-36, FDQ, and TWSTRS.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17190951     DOI： 10.1212/01.wnl.0000249310.25427.f2

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  17 in total

1.  What sample sizes for reliability and validity studies in neurology?

Authors:  Jeremy C Hobart; Stefan J Cano; Thomas T Warner; Alan J Thompson
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

Review 2.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

3.  Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.

Authors:  Cynthia L Comella; Susan H Fox; Kailash P Bhatia; Joel S Perlmutter; Hyder A Jinnah; Mateusz Zurowski; William M McDonald; Laura Marsh; Ami R Rosen; Tracy Waliczek; Laura J Wright; Wendy R Galpern; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

4.  Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment.

Authors:  Codrin Lungu; Andrew W Tarulli; Daniel Tarsy; Phillip Mongiovi; Veronique G Vanderhorst; Seward B Rutkove
Journal:  Clin Neurophysiol       Date:  2010-10-12       Impact factor: 3.708

5.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

6.  Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

Authors:  Margherita Fabbri; Maria Superbo; Giovanni Defazio; Cesa Lorella Maria Scaglione; Elena Antelmi; Giacomo Basini; Stefania Nassetti; Fabio Pizza; Rosaria Plasmati; Rocco Liguori
Journal:  Neurol Sci       Date:  2014-01-30       Impact factor: 3.307

Review 7.  The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.

Authors:  Maria Stamelou; Mark J Edwards; Mark Hallett; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

Review 8.  Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.

Authors:  Wolfgang H Jost; Harald Hefter; Andrea Stenner; Gerhard Reichel
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

9.  Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia.

Authors:  Hubert H Fernandez; Fernando Pagan; Fabio Danisi; David Greeley; Joseph Jankovic; Amit Verma; Kapil Sethi; Eric J Pappert
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-05-17

10.  Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia.

Authors:  Hubert H Fernandez; Eric J Pappert; Cynthia L Comella; Virgilio Gerald H Evidente; Daniel D Truong; Amit Verma; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.